Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan

Abstract

by Nobuyuki Shimozawa,Shigeo Takashima,Hiroki Kawai,Kazuo Kubota,Hideo Sasai,Kenji Orii,Megumi Ogawa andHidenori Ohnishi
Int. J. Neonatal Screen. 2021, 7(3), 58; https://doi.org/10.3390/ijns7030058 - 2022
Cited by 14 | Viewed by 3306
Abstract
We established a diagnostic system for adrenoleukodystrophy (ALD) and peroxisomal disorders (PD) over 35 years ago in Japan, and have diagnosed 237 families with ALD and more than 100 cases of PD other than ALD using biochemical and molecular analyses. In particular, since the only treatment for the cerebral form of ALD is hematopoietic stem cell transplantation at an early stage of onset, we have developed a protocol for the rapid diagnosis of ALD that can provide the measurements of the levels of very-long-chain fatty acids in the serum and genetic analysis within a few days. In addition, to improve the prognosis of patients with ALD, we are working on the detection of pre-symptomatic patients by familial analysis from the proband, and the introduction of newborn screening. In this review, we introduce the diagnostic and newborn screening approaches for ALD and PD in Japan. Full article
(This article belongs to the Collection Newborn Screening in Japan)